|
Resolution: standard / high Figure 2.
Pepstatin A inhibits the capacity of XS52 DC to present native PPD: (A) γ-irradiated XS52 DC were pulsed with PPD (100 μg/ml) in the presence or absence
of each protease inhibitor (100 μg/ml pepstatin A, 100 μM DCI, or 100 μM E-64) or
vehicle alone (1% DMSO or 15 mM NH4Cl). XS52 DC were then cultured for 2 days with the PPD-reactive Th1 or Th2 clone
in the continuous presence of the same inhibitor or vehicle alone. Data shown are
the mean ± SD (n = 3) of 3H-thymidine uptake in three representative experiments. (B) XS52 DC were incubated
with each of protease inhibitor (100 μg/ml pepstatin A, 100 μM DCI, or 100 μM E-64)
or vehicle alone (1% DMSO or 15 mM NH4Cl) for 16 hrs. Subsequently, cells were harvested and their viability was measured
by trypan blue.
Mohamadzadeh et al. Journal of Immune Based Therapies and Vaccines 2004 2:8 doi:10.1186/1476-8518-2-8 |